Literature DB >> 21543437

More than inflammation: interleukin-1beta polymorphisms and the lipid metabolism.

Mihai G Netea, Charles A Dinarello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21543437      PMCID： PMC3085203          DOI： 10.1210/jc.2011-0685

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  25 in total

1.  Intra-peritoneal administration of interleukin-1 beta induces impaired insulin release from the perfused rat pancreas.

Authors:  L Wogensen; S Helqvist; F Pociot; J Johannesen; J Reimers; T Mandrup-Poulsen; J Nerup
Journal:  Autoimmunity       Date:  1990       Impact factor: 2.815

2.  Chylomicron remnants stimulate release of interleukin-1beta by THP-1 cells.

Authors:  Takahiro Okumura; Yoshio Fujioka; Shinji Morimoto; Miho Masai; Tsuyoshi Sakoda; Takeshi Tsujino; Shin-ichiro Kashiwamura; Haruki Okamura; Mitsumasa Ohyanagi
Journal:  J Atheroscler Thromb       Date:  2006-02       Impact factor: 4.928

Review 3.  The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity.

Authors:  H W Harris; J E Gosnell; Z L Kumwenda
Journal:  J Endotoxin Res       Date:  2000

4.  Postprandial lipemia is associated with platelet and monocyte activation and increased monocyte cytokine expression in normolipemic men.

Authors:  Dianne A Hyson; Teresa G Paglieroni; Theodore Wun; John C Rutledge
Journal:  Clin Appl Thromb Hemost       Date:  2002-04       Impact factor: 2.389

5.  Increased interleukin-1alpha and interleukin-1beta production by macrophages of low-density lipoprotein receptor knock-out mice stimulated with lipopolysaccharide is CD11c/CD18-receptor mediated.

Authors:  M G Netea; P N Demacker; B J Kullberg; O C Boerman; I Verschueren; A F Stalenhoef; J W Van Der Meer
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

6.  Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications.

Authors:  Hunghui Chi; Emmanuel Messas; Robert A Levine; Dana T Graves; Salomon Amar
Journal:  Circulation       Date:  2004-09-07       Impact factor: 29.690

Review 7.  Regulation of lipid metabolism by cytokines during host defense.

Authors:  C Grunfeld; K R Feingold
Journal:  Nutrition       Date:  1996-01       Impact factor: 4.008

8.  Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice.

Authors:  Kikuo Isoda; Shojiro Sawada; Norio Ishigami; Taizo Matsuki; Koji Miyazaki; Masatoshi Kusuhara; Yoichiro Iwakura; Fumitaka Ohsuzu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-04-01       Impact factor: 8.311

9.  Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections.

Authors:  M G Netea; P N Demacker; B J Kullberg; O C Boerman; I Verschueren; A F Stalenhoef; J W van der Meer
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

10.  Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells.

Authors:  B Beutler; J Mahoney; N Le Trang; P Pekala; A Cerami
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307
View more
  3 in total

1.  Caspase-1 deficiency in mice reduces intestinal triglyceride absorption and hepatic triglyceride secretion.

Authors:  Janna A van Diepen; Rinke Stienstra; Irene O C M Vroegrijk; Sjoerd A A van den Berg; Daniela Salvatori; Guido J Hooiveld; Sander Kersten; Cees J Tack; Mihai G Netea; Johannes W A Smit; Leo A B Joosten; Louis M Havekes; Ko Willems van Dijk; Patrick C N Rensen
Journal:  J Lipid Res       Date:  2012-11-17       Impact factor: 5.922

2.  A Genome-Wide Functional Genomics Approach Identifies Susceptibility Pathways to Fungal Bloodstream Infection in Humans.

Authors:  Martin Jaeger; Vasiliki Matzaraki; Raúl Aguirre-Gamboa; Mark S Gresnigt; Xiaojing Chu; Melissa D Johnson; Marije Oosting; Sanne P Smeekens; Sebo Withoff; Iris Jonkers; John R Perfect; Frank L van de Veerdonk; Bart-Jan Kullberg; Leo A B Joosten; Yang Li; Cisca Wijmenga; Mihai G Netea; Vinod Kumar
Journal:  J Infect Dis       Date:  2019-07-31       Impact factor: 5.226

3.  Network pharmacology analysis and experimental validation to explore the mechanism of Bushao Tiaozhi capsule (BSTZC) on hyperlipidemia.

Authors:  Guanlin Xiao; Zhihao Zeng; Jieyi Jiang; Aili Xu; Sumei Li; Yangxue Li; Zhao Chen; Weitao Chen; Jingnian Zhang; Xiaoli Bi
Journal:  Sci Rep       Date:  2022-04-28       Impact factor: 4.996
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.